Pharmaceutical Executive - Pharmaceutical news and analysis. Pharma management, sales, marketing & finance

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
The Trouble with Transparency
Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger
A Lead Drug on the Way? All Eyes on FDA
Pfizer Quietly Updates Company Logo
AZs First Corporate Blog Falls Flat

More Blog Posts

FindPharma Careers
Featured Jobs

More Jobs

New & Noteworthy
Innovation Over Imitation
As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics.
Pharma's Emerging Leaders - Podcast series
Pharm Exec interviews some of this year's emerging leaders to learn their strategies for success.
Finding the Sweet Spot
How proper site activation and site enrollment can help you get the most from clinical trials.
The Book on Daniel
Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?
One Pill Makes You Small
The obesity pipeline, despite a hugely underserved market potentially worth $11 billion, is awfully thin.
Events
PHARM EXEC DIGEST EUROPE
Pharmaceutical Executive Digest Europe Have you read the latest issue of Pharmaceutical Executive Digest Europe yet?
Click here if you haven't.Click here to receive the Digest into your inbox every week.
SURVEY
With the launch of Windows 7, Microsoft is banking that big business will finally upgrade from Windows XP.
Is your pharmaceutical company planning on upgrading its operating system in the next year?
Yes, to Windows 7
No, we are happy with XP
No, we are happy with Vista
We're a Mac, not a PC
Other
Yes, to Windows 7
21%
No, we are happy with XP
57%
No, we are happy with Vista
14%
We're a Mac, not a PC
7%
Other
0%
Click here